ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021

Comments Invited On Centers Program

November 27, 1987

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003